Literature DB >> 33853877

Environmental sustainability and the carbon emissions of pharmaceuticals.

Cristina Richie1.   

Abstract

The US healthcare industry emits an estimated 479 million tonnes of carbon dioxide each year; nearly 8% of the country's total emissions. When assessed by sector, hospital care, clinical services, medical structures, and pharmaceuticals are the top emitters. For 15 years, research has been dedicated to the medical structures and equipment that contribute to carbon emissions. More recently, hospital care and clinical services have been examined. However, the carbon of pharmaceuticals is understudied. This article will focus on the carbon emissions of pharmaceuticals since they are consistently calculated to be among the top contributors to healthcare carbon and assess the factors that contribute to pharmaceutical carbon emissions. Specifically, overprescription, pharmaceutical waste, antibiotic resistance, routine prescriptions, non-adherence, drug dependency, lifestyle prescriptions, and drugs given due to a lack of preventive healthcare will be identified. Prescribing practices have environmental ramifications. Carbon reduction, when focused on pharmaceuticals, can lead to cleaner, more sustainable healthcare. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drugs and drug industry; environmental Ethics; ethics; public health ethics

Mesh:

Substances:

Year:  2021        PMID: 33853877     DOI: 10.1136/medethics-2020-106842

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  1 in total

1.  Environmental impact ratings that could drive positive environmental changes in the manufacture and use of pharmaceuticals.

Authors:  Amelia Cussans; Guy Harvey; Terry Kemple; Tracy Lyons; Mike Tomson; Angela Wilson
Journal:  BJGP Open       Date:  2022-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.